Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis
Part of paid clinical trials in Golden Valley, Minnesota.
- Sponsor
- Hoffmann-La Roche
- Study ID
- NCT05949580
- Status
- Recruiting
Conditions
- Relapsing Remitting Multiple Sclerosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MS Care Platform (icobrain ms and icompanion ms) — DEVICEThe MS care management platform consists of the following components: 1. icobrain ms which is a a cloud-based solution to quantify brain volume and brain abnormalities and changes thereof on MRI scans; 2. icompanion ms which consists of free participant mobile application (app) and a web portal for HCPs. The information collected in the icompanion ms patient app and icobrain ms is then brought together in the icompanion ms HCP web portal which allows a comprehensive overview of disease data for every single participant.
Study Details
The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.
Key Dates
- Start date
- Oct 21, 2024
- Status verified
- Jan 2026
- Primary completion
- Jun 30, 2027
- Completion
- Mar 31, 2028
Study Design
- Enrollment
- 500 participants (estimated)
Arms
- Arm: People with RRMSParticipants with relapsing-remitting multiple sclerosis (RRMS) will have to complete various questionnaire from which data will be collected for patient-reported outcomes (PROs) using the icompanion patient app and the HCPs will complete various questionnaires using the icompanion HCP portal.
Primary Outcome Measure
HCPs: Median of the System Usability Scale (SUS) Score Reported by Radiologists and Neurologists at Month 6 [ Time Frame: Month 6 ]
Central Contacts
- MN44358 https://forpatients.roche.com/888-662-6728 (U.S. Only)
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Minneapolis Clinic of Neurology | Golden Valley | Minnesota | 55422 | - |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | - |
| Jersey Shore University Medical Centre | Neptune City | New Jersey | 07753 | - |
Find similar trials in Golden Valley, MN
Related Studies
- Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)PHASE3 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Palo Alto, California
- The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot StudyRecruiting · SetPoint Medical Corporation · Atlanta, Georgia